<DOC>
	<DOCNO>NCT01993849</DOCNO>
	<brief_summary>To conduct pilot randomize placebo-controlled feasibility trial N-acetylcysteine ( NAC ) onychophagia , preliminarily assess tolerability effect pharmacotherapy young adult bite fingernail . It propose NAC help decrease fingernail biting .</brief_summary>
	<brief_title>Use NAC Fingernail Biting</brief_title>
	<detailed_description />
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>1 . Age 1830 2 . Fingernail biter â‰¥5 year 1 . Any unstable major DSMIV Axis I psychiatric disorder past month ( e.g. , psychotic disorder , bipolar disorder , major depressive disorder ) 2 . Current substance dependence past month 3 . Current unstable major medical disorder medical condition past 6 month ( e.g. , renal impairment ) 4 . Current pregnancy breastfeed 5 . Current seizure disorder asthma , due possible elevate risk adverse effect NAC individual condition 6 . Known hypersensitivity NAC 7 . Use carbamazepine nitroglycerin ( medication deem hazardous take NAC ) within 14 day study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Anxiety</keyword>
	<keyword>Impulse control</keyword>
	<keyword>Depression</keyword>
	<keyword>ADHD</keyword>
	<keyword>Fingernail Biting</keyword>
	<keyword>N-Acetylcysteine</keyword>
	<keyword>NAC</keyword>
</DOC>